Market Access Cultural intelligence is key in the global pharma landscape When I started my job as the head of intercontinental markets at Bristol Myers Squibb in February, I was prepared for a steep learning curve.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends